Cucurbitacins are naturally occurring organic compounds known as tetracyclic terpenes. While these are beneficial for health, ...

Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.

A recent study led by Associate Professor Takuya Yamamoto and Researcher May Nakajima-Koyama has revealed that maintaining a delicate balance between interferon-gamma (IFN-γ) and extracellular ...

Auron Therapeutics has raised a $27 million Series B financing that it will use to initiate clinical development of its lead experimental drug, AUTX-703, in blood cancers.

Loss to follow-up higher among men who are Black or Hispanic, or those who must travel farther to care facilities.

Yes, that’s right, a new study published in Food Science and Nutrition has revealed that the juice and seeds from this stunning fruit can potentially give you a range of health benefits. The ...

In a mouse model of medulloblastoma, OLIG2+ stem cells are immunostained green, with all nuclei labeled blue (DAPI). These OLIG2+ cells divide slowly to renew their population and to generate rapidly ...

Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of breast cancer, today issued the following ...

Nature Research Intelligence Topics enable transformational understanding and discovery in research by categorising any document into meaningful, accessible topics. Read this blog to understand ...

Faricimab is under clinical development by F. Hoffmann-La Roche and currently in Phase II for Non-Proliferative Diabetic Retinopathy (NPDR). According to GlobalData, Phase II drugs for ...

The effects of TCF1 on T-cell function and metabolic function were assessed in vitro. Conclusion: Downregulation of TCF1 in HIV infection impairs T-cell proliferative capacity by disrupting ...